Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06638671
PHASE4

Short-Term Metformin Use in Young, Healthy Adults: Impacts on Exercise Capacity

Sponsor: University of Virginia

View on ClinicalTrials.gov

Summary

Metformin is the most prescribed blood sugar (glucose)-lowering medication for patients diagnosed with type 2 diabetes mellitus (T2DM). Metformin stimulates glucose uptake in skeletal muscle similar to the effects of exercise, though, some studies report that metformin may decrease exercise capacity. The main question this study looks to answer is: • Does metformin alter exercise capacity? Participants will: * Complete 5 exercise tests on a stationary bike. * Undergo a body composition test. * Take metformin and placebo. * Complete food and symptom logs. The researchers hypothesize that: • Metformin will reduce aerobic capacity.

Official title: Short-Term Metformin Use in Young, Healthy Adults: Impacts on the Blood Lactate Response to Exercise and Time-to-exhaustion in a Placebo-controlled, Crossover Study

Key Details

Gender

All

Age Range

18 Years - 30 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2025-01-31

Completion Date

2026-04-01

Last Updated

2025-12-18

Healthy Volunteers

Yes

Interventions

DRUG

Metformin Hydrochloride

Participants will consume metformin or placebo in a randomized order. Participants will complete exercise visits during each treatment phase.

DRUG

Placebo

Participants will consume metformin or placebo in a randomized order. Participants will complete exercise visits during each treatment phase.

Locations (1)

University of Virginia

Charlottesville, Virginia, United States